Biostage (BSTG) Announces Groundbreaking Data from Cellspan Study with Mayo Clinic

Biostage, Inc. (Nasdaq: BSTG) announced significant, pre-clinical data, including the complete regeneration of a segment of the esophagus, from its collaborative large-animal study of its Cellspanâ„¢ organ implants with Mayo Clinic. Biostage will review this research in a conference call today at 9:00 am ET (details below).

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *